Kiromic Biopharma, Inc. Total Assets
Kiromic Biopharma, Inc. had Total Assets of $8.54 million as of 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-02-14
- 2024-12-31: Assets $8.54M.
- 2024-09-30: Assets $10.24M.
- 2024-06-30: Assets $12.46M.
- 2024-03-31: Assets $12.63M.
| Period end | Assets |
|---|---|
| 2024-12-31 | $8.54M 10-K · filed 2025-02-14 |
| 2024-09-30 | $10.24M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $12.46M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $12.63M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $12.17M 10-K · filed 2025-02-14 |
| 2023-09-30 | $14.23M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $13.64M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $13.11M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.97M 10-K · filed 2024-03-19 |
| 2022-09-30 | $13.02M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $19.52M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $25.89M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $30.73M 10-K · filed 2023-04-17 |
| 2021-09-30 | $38.96M 10-Q · filed 2022-03-11 |
| 2021-06-30 | $6.44M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $10.15M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $12.83M 10-K · filed 2022-04-08 |
| 2020-09-30 | $3.18M 10-Q · filed 2020-11-30 |
| 2019-12-31 | $2.65M 10-K · filed 2021-03-31 |